Evidence map›Paper›PMID 30355631›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2018

Cellular Prion Protein Mediates the Disruption of Hippocampal Synaptic Plasticity by Soluble Tau

Tomas Ondrejcak, Igor Klyubin, Grant T Corbett, Graham Fraser, Wei Hong, Alexandra J Mably, Matthew Gardener, Jayne Hammersley, Michael S Perkinton, Andrew Billinton and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed
6.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed, 116 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Topological confinement by a membrane anchor suppresses phase separation into protein aggregates: Implications for prion diseases.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  11. Article
  12. Article
  13. Article
  14. Rapidly reversible persistent long-term potentiation inhibition by patient-derived brain tau and amyloid ß proteins.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2024
    Article
  15. Article
  16. The associations between synaptic density and "A/T/N" biomarkers in Alzheimer's disease: AnJournal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2024
    Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 4 countries.

Tomas OndrejcakDepartment of Pharmacology and Therapeutics and Institute of Neuroscience, Trinity College Dublin, Dublin 2, Ireland.
Igor KlyubinDepartment of Pharmacology and Therapeutics and Institute of Neuroscience, Trinity College Dublin, Dublin 2, Ireland.
Grant T CorbettLaboratory for Neurodegenerative Research, Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, and Harvard Medical School, Boston, Massachusetts 02115.ORCID 0000-0003-3606-9686
Graham FraserNeuroscience, IMED Biotech Unit, AstraZeneca, Cambridge, CB21 6GH, United Kingdom, and.
Wei HongLaboratory for Neurodegenerative Research, Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, and Harvard Medical School, Boston, Massachusetts 02115.
Alexandra J MablyLaboratory for Neurodegenerative Research, Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, and Harvard Medical School, Boston, Massachusetts 02115.
Matthew GardenerAntibody Discovery and Protein Engineering, MedImmune, Granta Park, Cambridge, CB21 6GH, United Kingdom.
Jayne HammersleyAntibody Discovery and Protein Engineering, MedImmune, Granta Park, Cambridge, CB21 6GH, United Kingdom.
Michael S PerkintonNeuroscience, IMED Biotech Unit, AstraZeneca, Cambridge, CB21 6GH, United Kingdom, and.
Andrew BillintonNeuroscience, IMED Biotech Unit, AstraZeneca, Cambridge, CB21 6GH, United Kingdom, and.
Dominic M WalshLaboratory for Neurodegenerative Research, Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, and Harvard Medical School, Boston, Massachusetts 02115.ORCID 0000-0002-0718-6261
Michael J RowanDepartment of Pharmacology and Therapeutics and Institute of Neuroscience, Trinity College Dublin, Dublin 2, Ireland, mrowan@tcd.ie.
Brigham and Women's Hospital · USAstraZeneca (United Kingdom) · GBTrinity College Dublin · IERecombinant Antibody Technology (United Kingdom) · GB

Funding

Exploiting PrP for the diagnosis and treatment of protein aggregation diseasesR21AG047505 · NIA · BRIGHAM AND WOMEN'S HOSPITAL · PI WALSH, DOMINIC MARTIN · 2015 to 2016
$493k
NIA NIH HHS R21 AG047505
6 · The paper itself

Abstract

Intracellular neurofibrillary tangles (NFTs) composed of tau protein are a neuropathological hallmark of several neurodegenerative diseases, the most common of which is Alzheimer's disease (AD). For some time NFTs were considered the primary cause of synaptic dysfunction and neuronal death, however, more recent evidence suggests that soluble aggregates of tau are key drivers of disease. Here we investigated the effect of different tau species on synaptic plasticity in the male rat hippocampus

Indexed as

AgedAged, 80 and overAlzheimer DiseaseAngiogenesis InhibitorsAnimalsFemaleHippocampusHumansMaleNeuronal PlasticityPrion ProteinsPrPC ProteinsRatstau ProteinsAngiogenesis InhibitorsPrion ProteinsPrPC Proteinstau ProteinsAlzheimer's diseaseglutamatemicrotubule-associated protein tauprion proteinsynaptic plasticity

Identifiers

PMID30355631
PMCPMC6290298
OpenAlexW2898317625

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.